Eiichiro Satake

12PUBLICATIONS
64CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 01, 2026
miRNAs as cell-intrinsic epigenetic regulators in muscle in type 2 diabetes.

|Aug 07, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progression.

Zaipul I Md Dom, Salina Moon, Eiichiro Satake

|Oct 31, 2024
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins.

Hiroki Kobayashi, Helen C Looker, Katsuhito Ihara

|May 22, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes.

Zhuo Chen, Eiichiro Satake, Marcus G Pezzolesi

|Aug 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Hiroki Kobayashi, Helen C Looker, Eiichiro Satake

|Jul 15, 2021
Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.

Josyf C Mychaleckyj, Erkka Valo, Takaharu Ichimura

Pageof 2